NCT06014931 Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
| NCT ID | NCT06014931 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University |
| Condition | Post-intensive Care Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 202 participants |
| Start Date | 2024-03-13 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 202 participants in total. It began in 2024-03-13 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Intact cognitive skills are necessary for independent living, going to work, and managing finances, and any loss of cognitive skills places a burden on society akin to what is seen with Alzheimer's Disease and Related Dementias. The TelePORT Study (Telehealth-Enhanced Patient-Oriented Recovery Trajectories after Intensive Care) is the first post-intensive care syndrome longitudinal long-term cognitive impairment intervention study. The societal effect from long-term cognitive impairment after critical illness is great as many of these patients are employable adults or functional retirees.
Eligibility Criteria
Inclusion Criteria: * Adults (age ≥45) * Admitted to a medical or surgical ICU * Treated for ARF (with mechanical ventilation) and/or septic shock (with vasopressors) Exclusion Criteria: * hospice care at discharge or not expected to survive 6 months * no access to a computer or electronic device (e.g., tablet, smart phone) with cellular or WiFi connection for a telemedicine clinic visit * substance abuse or psych disorder that prevents independent living * inability to speak English * severe dementia preventing independent living prior to index hospitalization
Contact & Investigator
Leanne M Boehm, PhD
PRINCIPAL INVESTIGATOR
Vanderbilt University
Frequently Asked Questions
Who can join the NCT06014931 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Post-intensive Care Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06014931 currently recruiting?
Yes, NCT06014931 is actively recruiting participants. Contact the research team at leanne.boehm@vanderbilt.edu for enrollment information.
Where is the NCT06014931 trial being conducted?
This trial is being conducted at Columbus, United States, Nashville, United States.
Who is sponsoring the NCT06014931 clinical trial?
NCT06014931 is sponsored by Vanderbilt University. The principal investigator is Leanne M Boehm, PhD at Vanderbilt University. The trial plans to enroll 202 participants.